vs
NovoCure Ltd（NVCR）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
BRC Group Holdings, Inc.的季度营收约是NovoCure Ltd的1.1倍（$188.3M vs $174.1M），BRC Group Holdings, Inc.净利率更高（47.9% vs -40.9%，领先88.8%），NovoCure Ltd同比增速更快（12.3% vs -21.9%），过去两年NovoCure Ltd的营收复合增速更高（7.6% vs -15.4%）
NovoCure Ltd是一家全球肿瘤医疗企业，专注研发肿瘤治疗电场（TTFields）技术，推出可穿戴非侵入式癌症治疗设备，已获批用于胶质母细胞瘤、恶性胸膜间皮瘤、非小细胞肺癌等多个癌种，业务覆盖北美、欧洲及亚太地区。
NVCR vs RILY — 直观对比
营收规模更大
RILY
是对方的1.1倍
$174.1M
营收增速更快
NVCR
高出34.2%
-21.9%
净利率更高
RILY
高出88.8%
-40.9%
两年增速更快
NVCR
近两年复合增速
-15.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $174.1M | $188.3M |
| 净利润 | $-71.1M | $90.3M |
| 毛利率 | 77.6% | 79.5% |
| 营业利润率 | — | 32.3% |
| 净利率 | -40.9% | 47.9% |
| 营收同比 | 12.3% | -21.9% |
| 净利润同比 | -107.3% | 1710.8% |
| 每股收益（稀释后） | — | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVCRRILY
| Q1 26 | $174.1M | — | ||
| Q4 25 | $174.3M | $188.3M | ||
| Q3 25 | $167.2M | $215.3M | ||
| Q2 25 | $158.8M | $188.2M | ||
| Q1 25 | $155.0M | $197.2M | ||
| Q4 24 | $161.3M | $241.0M | ||
| Q3 24 | $155.1M | $225.5M | ||
| Q2 24 | $150.4M | $256.0M |
净利润NVCRRILY
| Q1 26 | $-71.1M | — | ||
| Q4 25 | $-24.5M | $90.3M | ||
| Q3 25 | $-37.3M | $91.1M | ||
| Q2 25 | $-40.1M | $139.5M | ||
| Q1 25 | $-34.3M | $-10.0M | ||
| Q4 24 | $-65.9M | $-5.6M | ||
| Q3 24 | $-30.6M | $-284.4M | ||
| Q2 24 | $-33.4M | $-433.6M |
毛利率NVCRRILY
| Q1 26 | 77.6% | — | ||
| Q4 25 | 75.8% | 79.5% | ||
| Q3 25 | 73.2% | 83.7% | ||
| Q2 25 | 73.9% | 81.3% | ||
| Q1 25 | 75.1% | 81.4% | ||
| Q4 24 | 79.2% | 79.8% | ||
| Q3 24 | 77.2% | 82.1% | ||
| Q2 24 | 77.0% | 84.5% |
营业利润率NVCRRILY
| Q1 26 | — | — | ||
| Q4 25 | -23.2% | 32.3% | ||
| Q3 25 | -21.5% | 30.4% | ||
| Q2 25 | -24.9% | 5.7% | ||
| Q1 25 | -24.4% | -31.2% | ||
| Q4 24 | -39.3% | -69.2% | ||
| Q3 24 | -20.7% | -36.4% | ||
| Q2 24 | -22.3% | -90.8% |
净利率NVCRRILY
| Q1 26 | -40.9% | — | ||
| Q4 25 | -14.1% | 47.9% | ||
| Q3 25 | -22.3% | 42.3% | ||
| Q2 25 | -25.3% | 74.1% | ||
| Q1 25 | -22.1% | -5.1% | ||
| Q4 24 | -40.9% | -2.3% | ||
| Q3 24 | -19.7% | -126.1% | ||
| Q2 24 | -22.2% | -169.4% |
每股收益（稀释后）NVCRRILY
| Q1 26 | — | — | ||
| Q4 25 | $-0.22 | $2.78 | ||
| Q3 25 | $-0.33 | $2.91 | ||
| Q2 25 | $-0.36 | $4.50 | ||
| Q1 25 | $-0.31 | $-0.39 | ||
| Q4 24 | $-0.61 | $-0.01 | ||
| Q3 24 | $-0.28 | $-9.39 | ||
| Q2 24 | $-0.31 | $-14.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $432.0M | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $330.7M | $-171.5M |
| 总资产 | $787.9M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NVCRRILY
| Q1 26 | $432.0M | — | ||
| Q4 25 | $93.5M | $226.6M | ||
| Q3 25 | $342.1M | $184.2M | ||
| Q2 25 | $149.6M | $267.4M | ||
| Q1 25 | $127.3M | $138.3M | ||
| Q4 24 | $163.8M | $146.9M | ||
| Q3 24 | $185.4M | $159.2M | ||
| Q2 24 | $164.8M | $236.9M |
总债务NVCRRILY
| Q1 26 | — | — | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益NVCRRILY
| Q1 26 | $330.7M | — | ||
| Q4 25 | $340.5M | $-171.5M | ||
| Q3 25 | $341.3M | $-260.5M | ||
| Q2 25 | $349.4M | $-351.7M | ||
| Q1 25 | $362.0M | $-496.8M | ||
| Q4 24 | $360.2M | $-488.2M | ||
| Q3 24 | $360.8M | $-497.6M | ||
| Q2 24 | $361.8M | $-218.3M |
总资产NVCRRILY
| Q1 26 | $787.9M | — | ||
| Q4 25 | $804.3M | $1.7B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $1.2B | $1.5B | ||
| Q4 24 | $1.2B | $1.8B | ||
| Q3 24 | $1.2B | $2.2B | ||
| Q2 24 | $1.2B | $3.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $26.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.29× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NVCRRILY
| Q1 26 | — | — | ||
| Q4 25 | $-18.0M | $26.2M | ||
| Q3 25 | $20.6M | $-60.6M | ||
| Q2 25 | $-15.9M | $-25.6M | ||
| Q1 25 | $-35.7M | $184.0K | ||
| Q4 24 | $-3.5M | $-2.7M | ||
| Q3 24 | $10.4M | $19.5M | ||
| Q2 24 | $-1.7M | $111.5M |
自由现金流NVCRRILY
| Q1 26 | — | — | ||
| Q4 25 | $-22.9M | — | ||
| Q3 25 | $14.9M | — | ||
| Q2 25 | $-21.4M | — | ||
| Q1 25 | $-46.3M | — | ||
| Q4 24 | $-12.4M | — | ||
| Q3 24 | $-307.0K | — | ||
| Q2 24 | $-13.2M | — |
自由现金流率NVCRRILY
| Q1 26 | — | — | ||
| Q4 25 | -13.1% | — | ||
| Q3 25 | 8.9% | — | ||
| Q2 25 | -13.5% | — | ||
| Q1 25 | -29.9% | — | ||
| Q4 24 | -7.7% | — | ||
| Q3 24 | -0.2% | — | ||
| Q2 24 | -8.8% | — |
资本支出强度NVCRRILY
| Q1 26 | — | — | ||
| Q4 25 | 2.8% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 6.8% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 6.9% | — | ||
| Q2 24 | 7.6% | — |
现金转化率NVCRRILY
| Q1 26 | — | — | ||
| Q4 25 | — | 0.29× | ||
| Q3 25 | — | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVCR
暂无分部数据
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
